(E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile

C29H23N3SSe2Si — CID 140963349

IUPAC(E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile
SMILESC[Si](C)(C)c1ccc2nc(/C(C#N)=C/c3ccc(N4c5ccccc5[Se]c5ccccc54)[se]3)sc2c1
InChIInChI=1S/C29H23N3SSe2Si/c1-36(2,3)21-13-14-22-25(17-21)33-29(31-22)19(18-30)16-20-12-15-28(34-20)32-23-8-4-6-10-26(23)35-27-11-7-5-9-24(27)32/h4-17H,1-3H3/b19-16+
InChIKeyFEYKQHCIHAIWGX-KNTRCKAVSA-N
MW631.60 g/mol
LogP5.40
Rot. Bonds4

About (E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile

(E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile (PubChem CID 140963349) has the molecular formula C29H23N3SSe2Si and a molecular weight of 631.60 g/mol. Its IUPAC name is (E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile.

Molecular Properties

Compound Name(E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile
PubChem CID140963349
Molecular FormulaC29H23N3SSe2Si
Molecular Weight631.60 g/mol
Exact Mass632.97
IUPAC Name(E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile
SMILESC[Si](C)(C)c1ccc2nc(/C(C#N)=C/c3ccc(N4c5ccccc5[Se]c5ccccc54)[se]3)sc2c1
InChIInChI=1S/C29H23N3SSe2Si/c1-36(2,3)21-13-14-22-25(17-21)33-29(31-22)19(18-30)16-20-12-15-28(34-20)32-23-8-4-6-10-26(23)35-27-11-7-5-9-24(27)32/h4-17H,1-3H3/b19-16+
InChIKeyFEYKQHCIHAIWGX-KNTRCKAVSA-N
XLogP5.40
TPSA39.92 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms36
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500631.60
LogP ≤ 55.40
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'conjugated_nitrile_group', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze (E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile?
The IUPAC name of (E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile (CID 140963349) is (E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile.
What is the SMILES notation for (E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile?
The canonical SMILES for (E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile is C[Si](C)(C)c1ccc2nc(/C(C#N)=C/c3ccc(N4c5ccccc5[Se]c5ccccc54)[se]3)sc2c1.
What is the InChIKey of (E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile?
The InChIKey is FEYKQHCIHAIWGX-KNTRCKAVSA-N. The full InChI is InChI=1S/C29H23N3SSe2Si/c1-36(2,3)21-13-14-22-25(17-21)33-29(31-22)19(18-30)16-20-12-15-28(34-20)32-23-8-4-6-10-26(23)35-27-11-7-5-9-24(27)32/h4-17H,1-3H3/b19-16+.
What are the key properties of (E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile?
(E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile has a molecular weight of 631.60 g/mol, XLogP of 5.40, 4 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-3-(5-phenoselenazin-10-ylselenophen-2-yl)-2-(6-trimethylsilyl-1,3-benzothiazol-2-yl)prop-2-enenitrile is sourced from PubChem (CID 140963349), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).